1. ICYMI: FDA’s Immediately-In-Effect Guidance on UDI Policy Regarding Compliance Dates for Class I and Unclassified Devices

    Last week, the U.S. Food and Drug Administration (FDA) released its immediately-in-effect (IIE) guidance document, "Unique Device Identification: Policy Regarding Compliance Dates for Class I and Unclassified Devices." According to the FDA, “the guidance will assist industry and FDA staff in understanding the Agency’s intentions regarding the enforcement of UDI requirements for certain class I and unclassified devices.

    Read More

  2. More Than 17,000 Pharmacies Have Submitted Credentialing Data in resQ

    Since NCPDP launched its resQ Pharmacy Credentialing Resource in early 2017, an average of 1,000 pharmacies per month have completed and submitted their profile credentials.

    Read More

  3. X12 Extends Public Review Periods Through January 31, 2018

    Based on comments and requests received from reviewers, X12 is extending the public review periods currently in progress for the following technical reports (implementation guides):

    Read More

  4. ICYMI: CHIME Suspends its National Patient ID Challenge

    The College of Healthcare Information Management Executives (CHIME) announced last week that after nearly two years of work and a great deal of deliberation, CHIME Healthcare Innovation Trust has decided to suspend the National Patient ID Challenge.

    Read More

  5. You Can Depend on HCIdea to Help You Get It Right the First Time

    Recent studies conducted by Porter Research® found most Payers and PBMs rely on the free NPPES file or their own data claims and internal sources to update their prescriber data.

    Read More

For problems with the site please contact us at webmaster@ncpdp.org